Data Dictionary RNC - Luxembourg - Revision history

Larysse at 14:56, 4 December 2025

2025-12-04T14:56:18Z

← Older revision		Revision as of 14:56, 4 December 2025
Line 1:		Line 1:
	<span style="display:none">forresearchers</span>		<span style="display:none">forresearchers</span>
			<span style="display:none">luxembourgcountry</span>
	Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page		Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page

Lucas: Update categories.

2025-12-02T13:27:30Z

Update categories.

← Older revision		Revision as of 13:27, 2 December 2025
Line 1:		Line 1:
	{{forresearchers}}		<span style="display:none">forresearchers</span>
	Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page		Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page

Victor at 20:28, 25 August 2024

2024-08-25T20:28:29Z

← Older revision		Revision as of 20:28, 25 August 2024
Line 106:		Line 106:
	\|}		\|}

	'''Table 4''': Histological characteristics of the ~~tumor~~.		'''Table 4''': Histological characteristics of the tumour.
	{\| class="wikitable"		{\| class="wikitable"
	\| Cytology procedure		\| Cytology procedure

Victor at 20:28, 25 August 2024

2024-08-25T20:28:14Z

← Older revision		Revision as of 20:28, 25 August 2024
Line 43:		Line 43:
	'''Table 3''': Clinical description of the disease and staging.		'''Table 3''': Clinical description of the disease and staging.
	{\| class="wikitable"		{\| class="wikitable"
	\| Order number of the ~~tumor~~		\| Order number of the tumour
	\|-		\|-
	\| RHC registration number of the ~~tumor~~		\| RHC registration number of the tumour
	\|-		\|-
	\| Date of registration of the ~~tumor~~		\| Date of registration of the tumour
	\|-		\|-
	\| Date of ~~tumor~~ diagnosis		\| Date of tumour diagnosis
	\|-		\|-
	\| Basis of diagnosis		\| Basis of diagnosis
Line 57:		Line 57:
	\| Laterality		\| Laterality
	\|-		\|-
	\| Multifocal ~~tumor~~		\| Multifocal tumour
	\|-		\|-
	\| Country of residence at the time of diagnosis		\| Country of residence at the time of diagnosis
Line 65:		Line 65:
	\| Locality of residence at the time of diagnosis		\| Locality of residence at the time of diagnosis
	\|-		\|-
	\| Circumstances of ~~tumor~~ discovery		\| Circumstances of tumour discovery
	\|-		\|-
	\| Family history		\| Family history
Line 91:		Line 91:
	\| Tests results (staging evaluation)		\| Tests results (staging evaluation)
	\|-		\|-
	\| Tests date of serum ~~tumor~~ markers		\| Tests date of serum tumour markers
	\|-		\|-
	\| Result of serum ~~tumor~~ markers		\| Result of serum tumour markers
	\|-		\|-
	\| Laboratory of serum ~~tumor~~ markers		\| Laboratory of serum tumour markers
	\|-		\|-
	\| Clinical ~~tumor~~ size		\| Clinical tumour size
	\|-		\|-
	\| Clinical lymph node involvement		\| Clinical lymph node involvement
Line 134:		Line 134:
	\| Capsular rupture		\| Capsular rupture
	\|-		\|-
	\| Percentage of ~~tumor~~ invasion		\| Percentage of tumour invasion
	\|-		\|-
	\| Distance from resection margins		\| Distance from resection margins
Line 140:		Line 140:
	\| Specific scores by location		\| Specific scores by location
	\|-		\|-
	\| Conducted analises of tissue ~~tumor~~ markers and molecular alterations		\| Conducted analises of tissue tumour markers and molecular alterations
	\|-		\|-
	\| Date of analises of tissue ~~tumor~~ markers and molecular alterations		\| Date of analises of tissue tumour markers and molecular alterations
	\|-		\|-
	\| Result of analises of tissue ~~tumor~~ markers and molecular alterations		\| Result of analises of tissue tumour markers and molecular alterations
	\|-		\|-
	\| Laboratory of analises of tissue ~~tumor~~ markers and molecular alterations		\| Laboratory of analises of tissue tumour markers and molecular alterations
	\|-		\|-
	\| Histological size		\| Histological size
Line 154:		Line 154:
	\| Number of examined and positive lymph nodes		\| Number of examined and positive lymph nodes
	\|-		\|-
	\| ~~Tumor~~ residue		\| Tumour residue
	\|-		\|-
	\| Pathological TNM,		\| Pathological TNM,
Line 167:		Line 167:
	\|}		\|}

	'''Table 5''': Revised diagnosis of the ~~tumor~~.		'''Table 5''': Revised diagnosis of the tumour.
	{\| class="wikitable"		{\| class="wikitable"
	\| Revised incidence date		\| Revised incidence date
Line 257:		Line 257:
	\|}		\|}

	'''Table 7''': ~~Tumor~~ follow-up.		'''Table 7''': Tumour follow-up.
	{\| class="wikitable"		{\| class="wikitable"
	\| Location		\| Location
Line 449:		Line 449:
	'''Table 1''': Examinations reports sent by the laboratories to RNC.		'''Table 1''': Examinations reports sent by the laboratories to RNC.
	{\| class="wikitable"		{\| class="wikitable"
	\| Analysis of ~~Tumor~~ Markers		\| Analysis of Tumour Markers
	\|-		\|-
	\| Analysis of Serum ~~Tumor~~ Markers		\| Analysis of Serum Tumour Markers
	\|-		\|-
	\| Analysis of Tissue ~~Tumor~~ Markers		\| Analysis of Tissue Tumour Markers
	\|-		\|-
	\| Analysis of Molecular Alterations with Predictive Value for Response to Chemotherapy or Targeted Therapy		\| Analysis of Molecular Alterations with Predictive Value for Response to Chemotherapy or Targeted Therapy
	\|-		\|-
	\| Cytology performed in cases of severe dysplasia and malignant ~~tumors~~		\| Cytology performed in cases of severe dysplasia and malignant tumours
	\|}		\|}

Francine at 14:19, 27 May 2024

2024-05-27T14:19:17Z

← Older revision		Revision as of 14:19, 27 May 2024
Line 1:		Line 1:
			{{forresearchers}}
	Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page		Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page

Francine at 11:56, 22 May 2024

2024-05-22T11:56:55Z

← Older revision		Revision as of 11:56, 22 May 2024
Line 1:		Line 1:
	Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page		Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page

	Source: [https://www.rnc.lu/Portals/5/Documents/~~aspects_legaux/RNC_Manuel%20qualité_version%20validée_1.4_2014%2007%2003_LIH~~.pdf Click here to learn more]		Source: [https://www.rnc.lu/Portals/5/Documents/RGD_RNC.pdf Click here to learn more]

	====Information provided by hospital cancer registries (RHC)====		====Information provided by hospital cancer registries (RHC)====

Francine at 20:43, 20 May 2024

2024-05-20T20:43:08Z

← Older revision		Revision as of 20:43, 20 May 2024
Line 1:		Line 1:
	Go back to [[Luxembourg]] page		Go back to [[Database: National Register of Cancer (RNC) (Luxembourg)]] page

			Source: [https://www.rnc.lu/Portals/5/Documents/aspects_legaux/RNC_Manuel%20qualité_version%20validée_1.4_2014%2007%2003_LIH.pdf Click here to learn more]

	====Information provided by hospital cancer registries (RHC)====		====Information provided by hospital cancer registries (RHC)====

Francine: Created page with "Go back to Luxembourg page ====Information provided by hospital cancer registries (RHC)==== '''Table 1''': Patient identification. {| class="wikitable" | National pseudo-anonymization RNC number of the patient |- | Date of birth |- | Gender |- | Country of birth |- | Hospital file number |- | RHC registration number |- | Country of the patient |- | Postal code of the patient |- | Municipality of the patient |- | Referring primary care physician |} '''Table 2''':..."

2023-07-19T19:37:04Z

Created page with "Go back to Luxembourg page ====Information provided by hospital cancer registries (RHC)==== '''Table 1''': Patient identification. {| class="wikitable" | National pseudo-anonymization RNC number of the patient |- | Date of birth |- | Gender |- | Country of birth |- | Hospital file number |- | RHC registration number |- | Country of the patient |- | Postal code of the patient |- | Municipality of the patient |- | Referring primary care physician |} '''Table 2''':..."

New page

Go back to [[Luxembourg]] page

====Information provided by hospital cancer registries (RHC)====
'''Table 1''': Patient identification.
{| class="wikitable"
| National pseudo-anonymization RNC number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country of birth
|-
| Hospital file number
|-
| RHC registration number
|-
| Country of the patient
|-
| Postal code of the patient
|-
| Municipality of the patient
|-
| Referring primary care physician
|}

'''Table 2''': Patient status.
{| class="wikitable"
| Vital status
|-
| Date of last contact
|-
| Date of death
|-
| Cause of death
|-
| Autopsy
|}

'''Table 3''': Clinical description of the disease and staging.
{| class="wikitable"
| Order number of the tumor
|-
| RHC registration number of the tumor
|-
| Date of registration of the tumor
|-
| Date of tumor diagnosis
|-
| Basis of diagnosis
|-
| ICD code (topography and morphology)
|-
| Laterality
|-
| Multifocal tumor
|-
| Country of residence at the time of diagnosis
|-
| Postal code of residence at the time of diagnosis
|-
| Locality of residence at the time of diagnosis
|-
| Circumstances of tumor discovery
|-
| Family history
|-
| Personal history
|-
| Comorbidities
|-
| Performance score (WHO/ECOG)
|-
| Risk factors
|-
| Results of clinical examination (Initial assessment)
|-
| Types of performed tests (Initial assessment)
|-
| Tests dates (Initial assessment)
|-
| Tests results (Initial assessment)
|-
| Types of performed tests (staging evaluation)
|-
| Tests dates (staging evaluation)
|-
| Tests results (staging evaluation)
|-
| Tests date of serum tumor markers
|-
| Result of serum tumor markers
|-
| Laboratory of serum tumor markers
|-
| Clinical tumor size
|-
| Clinical lymph node involvement
|-
| Clinical TNM
|-
| Clinical metastases at the time of diagnosis
|}

'''Table 4''': Histological characteristics of the tumor.
{| class="wikitable"
| Cytology procedure
|-
| Date of cytology procedure
|-
| Result of cytology procedure
|-
| Laboratory of cytology procedure
|-
| Biopsy procedure
|-
| Date of biopsy procedure
|-
| Result of biopsy procedure
|-
| Laboratory of biopsy procedure
|-
| Vascular invasion
|-
| Lymphatic invasion
|-
| Perineural sheath invasion
|-
| Vascular emboli
|-
| Capsular rupture
|-
| Percentage of tumor invasion
|-
| Distance from resection margins
|-
| Specific scores by location
|-
| Conducted analises of tissue tumor markers and molecular alterations
|-
| Date of analises of tissue tumor markers and molecular alterations
|-
| Result of analises of tissue tumor markers and molecular alterations
|-
| Laboratory of analises of tissue tumor markers and molecular alterations
|-
| Histological size
|-
| Pathological lymph node involvement
|-
| Number of examined and positive lymph nodes
|-
| Tumor residue
|-
| Pathological TNM,
|-
| Specific grade by location
|-
| Laboratory
|-
| Pathological Metastases at the time of diagnosis
|-
| Grouping by extension stages.
|}

'''Table 5''': Revised diagnosis of the tumor.
{| class="wikitable"
| Revised incidence date
|-
| Revised basis of diagnosis
|-
| Revised ICD code (topography and morphology)
|-
| Laterality
|-
| Laboratory
|}

'''Table 6''': Information on therapeutic management.
{| class="wikitable"
| Initial treatment performed
|-
| Inclusion in a therapeutic trial
|-
| Type of surgical intervention
|-
| Date of surgical intervention
|-
| Post-operative complications
|-
| Procedure for excision of regional lymph nodes
|-
| Surgeon's RNC identification number
|-
| Hospital facility
|-
| Date of discharge from hospital
|-
| Type of chemotherapy and drug molecules
|-
| Chemotherapy start date
|-
| Chemotherapy referring physician
|-
| Chemotherapy hospital facility.
|-
| Type of hormone therapy and drug molecules
|-
| Hormone terapy start date
|-
| Hormone terapy referring physician
|-
| Hormone therapy hospital facility
|-
| Type of radiotherapy
|-
| Radiotherapy irradiated fields
|-
| Radiotherapy start date
|-
| Radiotherapy total dose
|-
| Radiotherapy number of sessions
|-
| Radiotherapy referring physician
|-
| Radiotherapy center
|-
| Type of targeted therapy and drug molecules
|-
| Targeted Therapy start date
|-
| Targeted Therapy referring physician
|-
| Targeted Therapy hospital facility
|-
| Other Treatments
|-
| Date of genetic consultation
|-
| Location of genetic consultation.
|-
| Date of Multidisciplinary Consultation Meetings (RCP)
|-
| Location of RCP
|-
| Title of the RCP
|-
| RNC identification number of RCP attending physicians
|-
| Nature of RCP proposal
|-
| Proposed therapeutic protocol
|}

'''Table 7''': Tumor follow-up.
{| class="wikitable"
| Location
|-
| Date of first recurrence
|-
| Basis of diagnosis
|-
| Location of first distant metastasis
|-
| Date of first distant metastasis
|}

====Information provided by the National Breast Cancer Screening Program====

'''Table 1''': National RNC pseudo-anonymization number of the woman.
{| class="wikitable"
| Date of birth)
|-
| Country
|-
| Postal code
|-
| Locality (town/city)
|-
| Dates of Invitations to the Mammography Program
|-
| Dates of Participation in the Mammography Program
|-
| Dates of examinations conducted as part of the Mammography Program
|-
| Types of examinations conducted as part of the Mammography Program
|-
| Results of examinations conducted as part of the Mammography Program
|}

====Information provided by the National Health Fund (CNS)====

'''Table 1''': Data to be transmitted to RNC per patient (Databases of patients treated abroad).
{| class="wikitable"
| National RNC Pseudo-anonymization Number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country
|-
| Postal code
|-
| Locality (town/city)
|-
| Name and specialty of the physician who requested services abroad
|-
| Data on the pathology
|-
| Types of services
|-
| Dates of services
|-
| Locations of services
|}

'''Table 2''': Data to be transmitted to RNC per hospital stay for cancer.
{| class="wikitable"
| National RNC Pseudo-anonymization Number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country
|-
| Postal code
|-
| Locality (town/city)
|-
| ICD-10 Codes for the discharge diagnosis
|-
| Name of the hospital facility related to the considered hospital stay
|-
| Admission date
|-
| Discharge date
|-
| Mode of hospital discharge.
|}

==== Information provided by the Joint European Communities Health Insurance Scheme (RCAM) ====

'''Table 1''': Data to be transmitted to RNC per patient.
{| class="wikitable"
| National RNC Pseudo-anonymization Number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country
|-
| Postal code
|-
| Locality (town/city)
|-
| Name and specialty of the physician who requested services abroad
|-
| Data on the pathology
|-
| Types of services
|-
| Dates of services
|-
| Locations of services
|}

'''Table 2''': Data to be transmitted to RNC per hospital stay for cancer.
{| class="wikitable"
| National RNC Pseudo-anonymization Number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country
|-
| Postal code
|-
| Locality (town/city)
|-
| ICD-10 Codes for the discharge diagnosis
|-
| Name of the hospital facility related to the considered hospital stay
|-
| Admission date
|-
| Discharge date
|-
| Mode of hospital discharge
|}

====Information provided by the Directorate of Health (death certificates) ====

'''Table 1''': Data to be transmitted to RNC per deceased individual.
{| class="wikitable"
| National RNC Pseudo-anonymization Number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country (at the time of death)
|-
| Postal code (at the time of death)
|-
| Locality (at the time of death)
|-
| Date of death
|-
| Place of death
|-
| Primary cause of death (1 ICD-10 code)
|-
| Immediate diseases (up to 3 possible ICD-10 codes)
|-
| Concurrent diseases (up to 2 possible ICD-10 codes).
|}

==== Information provided by the Civil status register ====
'''Table 1''': Data to be transmitted to RNC per deceased individual.

{| class="wikitable"
| National RNC Pseudo-anonymization Number of the patient
|-
| Date of birth
|-
| Gender
|-
| Country (at the time of death)
|-
| Postal code (at the time of death)
|-
| Locality (at the time of death)
|-
| Date of death
|-
| Place of death
|}

====Information provided by the private medical analysis laboratories ====

'''Table 1''': Examinations reports sent by the laboratories to RNC.
{| class="wikitable"
| Analysis of Tumor Markers
|-
| Analysis of Serum Tumor Markers
|-
| Analysis of Tissue Tumor Markers
|-
| Analysis of Molecular Alterations with Predictive Value for Response to Chemotherapy or Targeted Therapy
|-
| Cytology performed in cases of severe dysplasia and malignant tumors
|}